1 in 10 women of childbearing age suffers from PCOS, which cause 80% infertility and miscarriage. PCOS patients have 50% chances to develop type 2 diabetes by age 45, 3x increase risk of endometrial cancer and 3x more likely to be diagnosed of anxiety and depression. No current cure for PCOS. Metformin is usually prescribed for PCOS but did not treat the underlying causes, in addition to causing side effects with the most severe effect is lactic acidosis. Hence, the need for effective formulation.

This formulation target hormonal pathway and lipid peroxidation pathway in women with PCOS. It reduces ovarian cysts with 28 days intake, improve ovulation, reduce testosterone level in women and regulate menstrual cyclicity to normal. This nutraceutical formulation will be packaged as capsules, with two different packaging ie 30 capsules and 60 capsules for 1 and 3-months usage respectively.

The innovation is a novel nutraceutical formulation designed to effectively manage and improve Polycystic Ovary Syndrome (PCOS) a major cause of infertility among women of childbearing age. Unlike conventional treatments like Metformin, which often fail to address the root causes and come with significant side effects, this formulation offers a holistic, side-effect-free solution that targets both the hormonal pathway and lipid peroxidation pathway, directly addressing the biochemical imbalances associated with PCOS & utilizing a specialized isolation method to preserve the bioactive compounds during production, ensuring high efficacy and stability of active ingredients.